F10 and neoplasm: However, given the strong heterogeneity of patients in terms of the primary tumor localization, the question as to whether the use of AC in general and the application of FXa or thrombin inhibitors more specifically might impact the outcome of ICI treatment might be better addressed in defined tumor entities with unmet clinical needs in improvements of ICI therapy.